Navigation Links
In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders

Hollywood, CA (PRWEB) March 12, 2013

The producers of In Focus with Martin Sheen are pleased to announce a new report showcasing how people battling mood disorders are receiving new hope through advanced medications.

In Focus Martin Sheen PBS is an independently produced television series airing in markets around the country on public television. The program is hosted by the legendary Martin Sheen, who is about to embark on his second half-century in American entertainment. Mr. Sheen has developed a reputation as one of Hollywood’s most respected actors during a career that includes more than 60 film appearances.

In Focus Martin Sheen is looking at the innovations in healthcare that are making a difference in the lives of patients, and for the millions of Americans dealing with some form of mood disorder, new medications are helping people lead healthy, happy lives.

In this new report, In Focus will be talking to mental health experts about how these new medications work to achieve the right chemistry in the brain to help people overcome mood disorders. Coupled with therapy, these medications are helping people live lives free from the suffering of many serious conditions like depression or bipolar disorder.

The producers of In Focus with Martin Sheen are hoping to debut the new report in May. Viewers can find air times and dates by checking their local listings. For more information about the reports or to offer other ideas related to this topic, In Focus with Martin Sheen can be reached through the show’s official website at or on Facebook at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
3. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
4. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
5. Vermillion Sharpens Focus and Streamlines Operations in 2012
6. Inverseon Focuses on Mucous and Smoking Cessation
7. First Statewide Biotech Meeting Focuses on Patient Access, Innovation
8. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
9. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
10. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
11. All the colors of a high-energy rainbow, in a tightly focused beam
Post Your Comments:
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):